BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Teva Women's Health, Inc. 

7155 E. Kemper Road

Cincinnati  Ohio  45249  U.S.A.
Phone: 513-731-9900 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Teva Women's Health, Inc. (TEVA) Announces Quartette™ (Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol) Tablets Now Available for the Prevention of Pregnancy in the United States 9/24/2013 11:06:01 AM    More...
New Data Presented Demonstrates Ovulatory Effect of Teva Women's Health, Inc. (TEVA)’s Investigational 28-Day Oral Contraceptive 5/8/2013 10:45:01 AM    More...
Teva Women's Health, Inc. (TEVA) to Present New Data at the 61st Annual Meeting of the American Congress of Obstetricians and Gynecologists 5/6/2013 9:19:09 AM    More...
Teva Women's Health, Inc. (TEVA)'s Plan B Cleared for Over-the-Counter Sale to Younger Teens 5/1/2013 7:19:48 AM    More...
Teva Women's Health, Inc. (TEVA) Announces for the First Time Results of Pivotal Phase III Study of Quartette™ (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) at the 68th Annual Meeting of American Society for Reproductive Medicine 10/24/2012 9:25:17 AM    More...
Teva Women's Health, Inc. (TEVA) Announces New Data on Phase III Investigational Progesterone Vaginal Ring at the 68th Annual Meeting of the American Society for Reproductive Medicine 10/23/2012 9:27:46 AM    More...
Teva Women's Health, Inc. (TEVA) to Present New Data at the 68th Annual Meeting of the American Society for Reproductive Medicine 10/18/2012 9:37:45 AM    More...
Teva Women's Health, Inc. (TEVA) Receives FDA Acceptance of Its New Drug Application for Quartette™ (Levonorgestrel/Ethinyl Estradiol Tablets and Ethinyl Estradiol tablets) for the Prevention of Pregnancy 8/13/2012 9:51:40 AM    More...
Watson Pharmaceuticals, Inc. (WPI) Confirms Court Decision Rejecting Teva Women's Health, Inc. (Formerly Known as Duramed Pharmaceuticals, Inc.) (TEVA)'s Motion to Prevent Launch of Generic SEASONIQUE(R) 6/17/2011 6:56:46 AM    More...
Kentucky Reaches $10M Settlement With TEVA Pharmaceuticals USA (TEVA), IVAX Pharmaceuticals, Inc. (IVX), Barr Laboratories (BRL), Sicor Inc. (SCRI), IVAX Corporation (IVX) and Teva Women's Health, Inc. (Formerly Known as Duramed Pharmaceuticals, Inc.) (TEVA) 8/16/2010 7:25:17 AM    More...
12345